Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outpatient cervical ripening

S K Sawai1, W F O'Brien

  • 1University of South Florida, Tampa, USA.

Clinical Obstetrics and Gynecology
|June 1, 1995
PubMed
Summary

Prostaglandin E2 (PGE2) shows promise for outpatient cervical ripening, building on inpatient data. Further studies are needed to establish optimal dosage and delivery for safe and effective outpatient use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2004
Same author

Cocaine affects prostaglandin production in human umbilical cord cell cultures.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2004
Same author

Sulindac to prevent recurrent preterm labor: a randomized controlled trial.

Obstetrics and gynecology·2001
Same author

Tuberculosis in North Carolina: trends across two decades, 1980-1999.

Emerging infectious diseases·2001
Same author

Safety and efficacy of misoprostol orally and vaginally: a randomized trial.

Obstetrics and gynecology·2001
Same author

Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants.

American journal of obstetrics and gynecology·2000

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Pharmacology

Background:

  • Limited data exists on prostaglandin E2 (PGE2) for outpatient cervical ripening.
  • Inpatient studies show PGE2 favorably alters cervical score, reduces failed inductions, and shortens labor.
  • Existing inpatient studies have significant variations, limiting extrapolation to outpatient settings.

Purpose of the Study:

  • To review the efficacy and safety of PGE2 as an outpatient cervical ripening agent.
  • To explore the potential for developing new PGE2 formulations for enhanced patient comfort and ease of administration.
  • To stimulate further research into cost-effective outpatient cervical ripening methods.

Main Methods:

  • Review of existing inpatient studies on PGE2 for cervical ripening.
  • Analysis of factors contributing to variability in study designs and outcomes.
  • Discussion of the potential for novel PGE2 formulations, such as intravaginal applications.

Main Results:

  • Inpatient PGE2 use is associated with improved cervical scores, reduced instrumental deliveries, and decreased oxytocin requirements.
  • Maternal side effects of inpatient PGE2 are minimal, with no adverse neonatal outcomes reported.
  • Significant heterogeneity in study designs, PGE2 formulations, and patient selection criteria complicates direct comparisons.

Conclusions:

  • PGE2 demonstrates efficacy in inpatient cervical ripening, with a favorable safety profile.
  • Outpatient cervical ripening with PGE2 warrants further controlled investigation to determine optimal dosing and delivery methods.
  • Development of convenient and cost-effective outpatient PGE2 formulations could improve patient care and reduce healthcare costs.

Related Experiment Videos